Continuing Education  » Neurology  » Canine Degenerative Myelopathy: From Gene Mutation Discovery to Clinical Trials

Canine Degenerative Myelopathy: From Gene Mutation Discovery to Clinical Trials

CE Event Information

  • Description:
    Degenerative myelopathy (DM) is an inherited, adult-onset disease of the spinal cord causing progressive weakness and paralysis of the hind limbs and eventually all limbs. DM has clinical, histopathologic, and genetic parallels to amyotrophic lateral sclerosis (ALS - Lou Gehrig's disease) in humans.

    Mutations in an enzyme that converts superoxide to water and hydrogen peroxide, superoxide dismutase 1 (SOD1), have been linked to DM and human ALS. These discoveries have guided studies to further understand natural history, establish biomarkers, and initiate clinical trials for therapeutic strategies.

    Join us in this webinar for a better understanding of DM including:
    - Genetic testing results as a risk factor for canine degenerative myelopathy
    - The neurologic progression in affected patients in terms of disease spread and changes in neuroanatomic localization
    - The pathophysiology of the mutated SOD1 protein and its consequences in the multifactorial pathogenesis of canine degenerative myelopathy
    - A platform of clinical trial designs and their potential applications in veterinary medicine

    Running time: 58 mins

    Fee: Free for Premium Membership subscribers or
    pay-per-view ($28)
  • Sponsor: AKC Canine Health Foundation
  • Presenter(s): Joan R. Coates, DVM, MS, Diplomate ACVIM (Neurology)
  • Fee (Basic Membership): $28